Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and...

Tue Jun 17, 2008 10:28am EDT

* Reuters is not responsible for the content in this press release.

Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations
and Data Management
Move further expands PROMETRIKA's focus in key areas in contract research
including clinical trial planning and execution, clinical monitoring, and data
management/electronic data capture.

CAMBRIDGE, Mass., June 17 /PRNewswire/ -- PROMETRIKA, LLC, a contract
research organization providing a full range of clinical research services for
clients in pharmaceuticals, biologics and medical devices, today announced
that Faith Haines Kolb has joined the company as senior director of clinical
operations and data management.  With more than 19 years of experience in
clinical research, Ms. Kolb has set up and managed multiple large scale
clinical research programs from planning through all phases of execution, data
management, and reporting.
    "Faith Haines Kolb is one of the most experienced clinical research
professionals working in the field today.  As we continue to expand our
services in the clinical research areas that are critical for our clients at
PROMETRIKA, her demonstrated strengths in project management, monitoring,
electronic data capture, and working successfully with global research
networks will be a tremendous asset for us moving forward," said Miganush
Stepanians, PhD, president and CEO of PROMETRIKA.
    Prior to joining PROMETRIKA, Ms. Kolb was chief technical officer at
Averion International Corporation, an international clinical research
organization.  At Averion she was responsible for the company's operational
performance in the United States.  Prior to joining Averion, she was director
of clinical IT at PAREXEL International Corporation.
    "In my work I have seen the many challenges in pharmaceutical product
development facing companies in the U.S. and around the world.  With a strong
focus on improving clinical research services for pharmaceutical,
biotechnology and medical device companies, PROMETRIKA is setting a new
standard in terms of efficiency and quality control for clinical trials. I am
very pleased to be joining this dynamic team," Ms. Kolb added.
    The clinical operations team at PROMETRIKA provides research planning and
execution services to support product development in pharmaceuticals,
biologics and medical devices for companies around the world.  Team leaders
are responsible for project planning and management, including monitoring
enrollment, research schedules, third party vendor management, budgeting and
performance metrics.  They also coordinate services related to data
management, biostatistics and medical writing for data collection and
analysis, internal and external reporting, and regulatory filings.
    According to a research study by CMSInfo, spending on clinical trials in
the United States reached $24 billion in 2005, and it is projected to rise to
$32.1 billion by 2011.  The Congressional Budget Office in the United States
estimates that by 2003 the average cost to develop a drug that represents a
new molecular entity (NME) reached $802 million and the development timeline
for NME drugs required an average of 7.5 years of clinical stage research.
    "Increasingly, clients are looking to us for new approaches involving
electronic data capture and other technologies that can maximize research
efficiency without compromising quality and accuracy.  With Faith's experience
in these areas, PROMETRIKA is better prepared than ever before to be a
comprehensive resource to help our clients plan and execute strategic and
successful clinical research programs," Ms. Stepanians added.
    Founded in 2003, PROMETRIKA, LLC, is a full service contract research
organization with headquarters in Cambridge, MA.  The company provides a full
range of clinical research services to pharmaceutical, biotechnology and
medical device companies.  PROMETRIKA's team has managed hundreds of clinical
trials from Phase 1 pharmacokinetic crossover trials to Phase 4 long-term
multi-center studies.  The company has extensive experience in all areas of
clinical trial management, including strategic planning, data collection and
analysis, and regulatory filings, including new drug applications in the U.S.
and Europe.  For additional information please visit

Sara Lizzo, +1-212-253-8881, for PROMETRIKA, LLC
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.